A detailed history of State Street Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, State Street Corp holds 19,500,683 shares of TEVA stock, worth $437 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,500,683
Previous 17,722,415 10.03%
Holding current value
$437 Million
Previous $288 Million 22.02%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $28.1 Million - $33.7 Million
1,778,268 Added 10.03%
19,500,683 $351 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $19.2 Million - $26.1 Million
1,499,143 Added 9.24%
17,722,415 $288 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $1.52 Million - $2.06 Million
-142,754 Reduced 0.87%
16,223,272 $229 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $2.93 Million - $3.83 Million
360,683 Added 2.25%
16,366,026 $171 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $3.23 Million - $4.62 Million
431,999 Added 2.77%
16,005,343 $163 Million
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $28.7 Million - $37.8 Million
-3,991,484 Reduced 20.4%
15,573,344 $117 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $37.1 Million - $50.5 Million
4,441,883 Added 29.37%
19,564,828 $173 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $1.76 Million - $2.1 Million
221,012 Added 1.48%
15,122,945 $138 Million
Q3 2022

Nov 15, 2022

BUY
$6.86 - $11.95 $7.24 Million - $12.6 Million
1,055,920 Added 7.63%
14,901,933 $120 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $12.9 Million - $18.1 Million
-1,744,479 Reduced 11.19%
13,846,013 $104 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $13.8 Million - $17.7 Million
-1,882,500 Reduced 10.77%
15,590,492 $146 Million
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $478,542 - $617,259
-60,575 Reduced 0.35%
17,472,992 $140 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $9.47 Million - $11.5 Million
1,130,428 Added 6.89%
17,533,567 $171 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $1.53 Million - $1.78 Million
-154,144 Reduced 0.93%
16,403,139 $162 Million
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $1.77 Million - $2.2 Million
-171,602 Reduced 1.03%
16,557,283 $191 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $2.12 Million - $2.72 Million
246,762 Added 1.5%
16,728,885 $161 Million
Q3 2020

Nov 10, 2020

BUY
$8.57 - $12.69 $7 Million - $10.4 Million
817,268 Added 5.22%
16,482,123 $149 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $2.13 Million - $3.44 Million
261,870 Added 1.7%
15,664,855 $193 Million
Q1 2020

May 11, 2020

BUY
$6.69 - $13.45 $103 Million - $207 Million
15,402,985 New
15,402,985 $138 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.